Novozymes A/S (CPH:NSIS.B)
Denmark · Delayed Price · Currency is DKK 411.20
+1.00 (0.24%)
Jul 24, 2026, 4:59 PM CET
Novozymes Market Cap
Novozymes has a market cap or net worth of 191.58 billion as of July 24, 2026. Its market cap has decreased by -7.25% in one year.
Market Cap
191.58B
Enterprise Value
213.15B
Revenue
31.39B
Ranking
n/a
PE Ratio
43.03
Stock Price
411.20
ChartMarket Cap Chart
Since February 26, 2001, Novozymes's market cap has increased from 14.15B to 191.58B, an increase of 1,254.12%. That is a compound annual growth rate of 10.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 191.58B | 0.89% |
| Dec 30, 2025 | 189.89B | 0.24% |
| Dec 30, 2024 | 189.43B | 84.24% |
| Dec 29, 2023 | 102.82B | 5.66% |
| Dec 30, 2022 | 97.30B | -34.61% |
| Dec 30, 2021 | 148.80B | 51.92% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DSV A/S | 345.86B |
| Danske Bank | 287.61B |
| A.P. Møller - Mærsk | 241.20B |
| Ørsted | 197.96B |
| Vestas Wind Systems | 170.48B |
| Carlsberg | 127.76B |
| Genmab | 115.33B |
| Tryg A/S | 92.60B |